Bronchopulmonary Dysplasia

• 

  Subject Areas on Research

  • A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia. 
  • A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants. 
  • Accelerated thymic maturation and autoreactive T cells in bronchopulmonary dysplasia. 
  • Acute effects of inhaled nitric oxide on pulmonary and cardiac function in preterm infants with evolving bronchopulmonary dysplasia. 
  • Agreement of an echocardiogram-based diagnosis of pulmonary hypertension in infants at risk for bronchopulmonary dysplasia among masked reviewers. 
  • An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants. 
  • Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. 
  • Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants. 
  • Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants. 
  • Association between Policy Changes for Oxygen Saturation Alarm Settings and Neonatal Morbidity and Mortality in Infants Born Very Preterm. 
  • Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants. 
  • Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants. 
  • Association of Adverse Hearing, Growth, and Discharge Age Outcomes With Postnatal Cytomegalovirus Infection in Infants With Very Low Birth Weight. 
  • Association of Atrial Septal Defects and Bronchopulmonary Dysplasia in Premature Infants. 
  • Behavior Profiles at 2 Years for Children Born Extremely Preterm with Bronchopulmonary Dysplasia. 
  • Black Race Is Associated with a Lower Risk of Bronchopulmonary Dysplasia. 
  • Blood Cytokine Profiles Associated with Distinct Patterns of Bronchopulmonary Dysplasia among Extremely Low Birth Weight Infants. 
  • Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia. 
  • Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia? 
  • Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. 
  • Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study. 
  • Bronchopulmonary dysplasia impairs L-type amino acid transporter-1 expression in human and baboon lung. 
  • Candida pneumonia in a term infant after prolonged use of inhaled corticosteroids for bronchopulmonary dysplasia (BPD). 
  • Comparative effectiveness of surfactant preparations in premature infants. 
  • Contributions of infertility treatment to very-low-birth-weight multiple birth infants receiving neonatal intensive care. 
  • Contributions of the NICHD neonatal research network to the diagnosis, prevention, and treatment of bronchopulmonary dysplasia. 
  • Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques. 
  • Development and validation of the Proxy-Reported Pulmonary Outcomes Scale for premature infants. 
  • Developmental outcomes of infants with bronchopulmonary dysplasia: comparison with other medically fragile infants. 
  • Developmental regulation of p66Shc is altered by bronchopulmonary dysplasia in baboons and humans. 
  • Differences in Eccentricity Index and Systolic-Diastolic Ratio in Extremely Low-Birth-Weight Infants with Bronchopulmonary Dysplasia at Risk of Pulmonary Hypertension. 
  • Diuretic exposure in premature infants from 1997 to 2011. 
  • Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants. 
  • Duration of noninvasive respiratory support and risk for bronchopulmonary dysplasia or death. 
  • Early CPAP versus surfactant in extremely preterm infants. 
  • Effect of Cord Blood Magnesium Level at Birth on Non-neurologic Neonatal Outcomes. 
  • Exome sequencing identifies gene variants and networks associated with extreme respiratory outcomes following preterm birth. 
  • Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants. 
  • Gastrin-releasing peptide, immune responses, and lung disease. 
  • Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth. 
  • High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. 
  • Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia. 
  • Hypocarbia in the ventilated preterm infant and its effect on intraventricular haemorrhage and bronchopulmonary dysplasia. 
  • Immunomodulatory functions of the diffuse neuroendocrine system: implications for bronchopulmonary dysplasia. 
  • Impact of Diuretic Therapy in the Treatment of Bronchopulmonary Dysplasia and Acute Kidney Injury in the Neonatal Population. 
  • Improved survival and neurodevelopmental outcomes among extremely premature infants born near the limit of viability. 
  • In-hospital outcomes of premature infants with severe bronchopulmonary dysplasia. 
  • Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats. 
  • Integrated genomic analyses in bronchopulmonary dysplasia. 
  • Intermittent hypoxia during recovery from neonatal hyperoxic lung injury causes long-term impairment of alveolar development: A new rat model of BPD. 
  • Introduction. 
  • Long-term morbidities associated with vocal cord paralysis after surgical closure of a patent ductus arteriosus in extremely low birth weight infants. 
  • Lung volume recruitment during high-frequency ventilation. 
  • Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018. 
  • Neonatal lung remodeling: structural, inflammatory, and ventilator-induced injury. 
  • PaCO2 in surfactant, positive pressure, and oxygenation randomised trial (SUPPORT). 
  • Postnatal Cytomegalovirus Infection and the Risk for Bronchopulmonary Dysplasia. 
  • Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. 
  • Prevention and management of bronchopulmonary dysplasia: Lessons learned from the neonatal research network. 
  • Prevention of bronchopulmonary dysplasia. 
  • Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infants. 
  • Reliability of CXR for the diagnosis of bronchopulmonary dysplasia. 
  • Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium. 
  • Respiratory Support for Very Low Birth Weight Infants Receiving Dexamethasone. 
  • Risk Factors and In-Hospital Outcomes following Tracheostomy in Infants. 
  • Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. 
  • Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study. 
  • Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial. 
  • Sildenafil Exposure in the Neonatal Intensive Care Unit. 
  • Sildenafil and retinopathy of prematurity risk in very low birth weight infants. 
  • Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes. 
  • Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. 
  • Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia. 
  • Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease. 
  • Variation in Gastrostomy Tube Placement in Premature Infants in the United States. 
• 

  Keywords of People

  • Sunday, Mary Elizabeth Anne, Professor of Pathology, Cell Biology